← Leaderboards
Adam S Morgenthau
Icahn School Of Medicine At Mount Sinai
$825,670
Attributed
$1,651,339
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $827.4K · FY2024–25$1M$750K$500K$250K$0
'24
'25
Funding mix
By agency
NIH$1,651,339 · 1
By mechanism
R01$1,651,339 · 1
Top collaborators
- Zahi A. Fayad2 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Ankit Ashok Parekh$4,050,242
- Thomas B Hildebrandt$10,328,843
- Indu A Ayappa$10,906,648
- Marta Filizola$11,220,258
- Girish Nitin Nadkarni$10,989,187
Others in their field
Other Rising Stars on “Adverse Event”
- Lauren Miller · Technical Resources International, Inc.$31,120,905
- Cynthia M Visness · Rho Federal Systems Division, Inc.$14,006,776
- Cathie Snyder · Rho Federal Systems Division, Inc.$13,688,224
- Jinsy Andrews · Columbia University Health Sciences$11,474,975
- Benjamin M Greenberg · Ut Southwestern Medical Center$11,474,975
- Eric Anderson · Columbia University Health Sciences$11,474,975
Research focus
Adverse EventFibrogenesisAgreementAmericanAffectAdrenal Cortex HormonesArtificial Intelligence ModelBiopsyCardiacCardiac SarcoidosisCardiac VolumeCardiometabolismCategoriesClinical CareClinical DataCross-Sectional StudiesDiagnosisDisease PrognosisDoseEnrollmentEvaluationEventExtracellularFibrosis
Grant awards (2)
Advanced multi-parametric 18F-FDG PET and MRI imaging parameters of response to immune suppressant therapy in patients with active cardiac sarcoidosis$823,983
R01 · FY2025 · HL
Advanced multi-parametric 18F-FDG PET and MRI imaging parameters of response to immune suppressant therapy in patients with active cardiac sarcoidosis$827,356
R01 · FY2024 · HL